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During an acute inflammation the number of circulating monocytes increases,
and a large proportion of these cells migrate to the site of inflammation and
differentiate into macrophages (1). In previous reports (2-5) we described a
factor stimulating the monocyte production, called factor increasing monocyto-
poiesis (FIM),' occurring in the circulation of mice and rabbits during the onset
of an inflammation. FIM has been fairly well characterized (5, 6), and others
have reported (7) a similar factor during an inflammatory response. This factor
is a protein of ^"20 X 10' mol wt that accelerates the rate of division of
promonocytes and monoblasts in vivo and is not CSF-1 (3, 5).
FIM is not detectable in the circulation of normal mice and rabbits with the
two available bioassay methods, which determine the increase of the number of
blood monocytes after intravenous injection of the factor into untreated animals
(2, 5), or establish the increased rate of the proliferation of a macrophage cell
line in vitro (4). FIM is detectable in the circulation during the initial phase of
an inflammatory reaction and indications have been obtained (8) that this factor
is produced at the site of inflammation . This paper reports a study performed
to establish the cellular origin of FIM and to determine the kinetics of its
production and release.
Materials and Methods
Animals. Specific pathogen-free, 6-12-wk-old male Swiss (CPB:SE) mice obtained
from The Central Institute for the Breeding of Laboratory Animals (Zeist, The Nether-
lands) were used in all but a few experiments were done on male C57BL/LiARij (C57BL)
and female CBA/BrARij (CBA) mice obtained from REPGO-TNO (Rijswijk, The Neth-
erlands). All animals were maintained on a 12-h light/dark cycle, given sterilized food
(type 1410; Hope Farms, Woerden, The Netherlands) and tap water ad libitum, and were
not used before the 7th day after arrival to allow time for acclimatization to the new
environment.
This study was supported in part by the Netherlands Asthma Foundation and the Foundation for
Medical Research (FUNGO), which is subsidized by the Netherlands Organization for the Advance-
ment of Pure Scientific Research (ZWO). Support has been given by Beecham Research Laboratories,
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' Abbreviations used in this paper:
￿
FIM, factor increasing monocytopoiesis; ppFIM, partially
purified FIM.
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Peritoneal Macrophages . Peritoneal macrophages were collected from chloroform-
anesthetized animals by lavage with 2 ml PBS containing 50 U/ml heparin . The cells were
counted in duplicate with a Coulter counter model ZF (Hoek-Loos, Schiedam, The
Netherlands), checked for viability by trypan-blue exclusion, and identified in cytocentri-
fuge preparations stained with Giemsa stain (2) . If the viability was <95% the suspensions
were discarded . Suspensions of peritoneal cells from normal mice contained 2.3 (± 0.6
SD) X 106 cells/ml of which 76.9% (± 4.2 SD) were macrophages, 21 .6% (± 4.6 SD)
lymphocytes, and 1 .5% (± 2 .5 SD) granulocytes .
Alveolar Macrophages .
￿
Alveolar macrophages were harvested from animals anesthe-
tized with an intravenous injection of 45 mg pentobarbitone sodium per kilogram body
wt (Sanofi Sante Animale, Paris, France) . After perfusion of the lungs with 5 ml 0.6 mM
EDTA in PBS (PBS-EDTA) to remove monocytes from the blood vessels, the alveolar
cells were collected by bronchial lavage with 15 ml PBS-EDTA at 37°C (9) . If the viability
was <95%, the suspensions were discarded . The cell yield of lavage amounted to 0.93 (±
0.24 SD) X 10 6 cells per mouse, 99.2% (± 2.3 SD) of which were macrophages and 0.8%
(± 2.5 SD) lymphocytes, as identified in cytocentrifuge preparations ; there were no
granulocytes (± 1 .3 SD) .
(:ell Lines.
￿
Cells of two continuous macrophage cell lines, PU5-1 .8 (PU5) (10, 11) and
J774.1 (J774) (11, 12), were obtained from end-log-phase cultures in RPMI 1640 medium
supplemented with 10% FCS, 1,000 U/ml sodium penicillin G (Gist-Brocades NV, Delft,
The Netherlands), 50 ug/ml streptomycin (Gist-Brocades NV), and 2.0 mM L-glutamine .
Murine lymphoblastic cells (L1210 ; kindly donated by Dr . E . R . Rijke, Department of
Clinical Immunology, Utrecht University Hospital, The Netherlands) were cultured in
suspension in RPMI 1640 medium supplemented with 10% FCS, 1,000 U/ml sodium
penicillin G (Gist-Brocades), 50 ug/ml streptomycin (Gist-Brocades), and 2.0 MM L-
glutamine .
Blood Lymphocytes and Granulocytes. Blood lymphocytes and granulocytes were ob-
tained from heparinized blood drawn by cardiac puncture from chloroform-anesthetized
animals. After differential centrifugation of the blood (diluted fivefold with PBS) on a
Ficoll-Hypaque gradient, the lymphocyte-rich interface layer was collected and washed
four times with PBS containing 0.5 U/ml heparin (PBS-heparin) . In this suspension, in
which lymphocytes predominate (87%), the proportion of granulocytes was 7% (± 5 SD)
and monocytes accounted for 6% (± 5 SD) . The viability of the cells, as checked by trypan-
blue exclusion, was at least 95% . A granulocyte-rich cell suspension was prepared from
the pellet of the Ficoll-Hypaque gradient by sedimentation of the erythrocytes with a 5%
solution of dextran (mol wt 200,000) in PBS, followed by two washes with PBS-heparin,
removal of the remaining erythrocytes by hypotonic lysis, and two additional washes with
PBS-heparin . In this suspension enriched in granulocytes (76%), monocytes accounted for
1 % (± 1 SD) and lymphocytes for 23% (± 10 SD) . If the viability of the cells was <95%,
the suspensions were discarded .
Cell Lysates.
￿
Lysates of various types of cell were prepared as described elsewhere (3) .
In short, 10' cells were suspended in 1 ml of pyrogen-free distilled water, quick-frozen to
-70° C, and then lyophilized at -20 °C . After addition of 1 ml sterile pyrogen-free saline,
the suspension was stirred, allowed to stand for 5 min at VC, C, and then passed through a
0.45-jum Millex filter (Millipore, Molsheim, France) to be assayed for FIM activity .
Cell Culture.
￿
The cell suspensions were centrifuged at 120 g for 10 min at 4°C, after
which the cells were resuspended in RPMI at a concentration of 10' viable cells/ml and
incubated on Teflon film dishes (13) or microtiter plates (Nunc Products, Roskilde,
Denmark) in a humidified atmosphere of 7 .5% CO z in air at 37°C . Preopsonized latex
was used as phagocytic stimulus (latex-to-cell ratio ^-100:1) . Polystyrene latex (0.81 jm
diameter ; Difco Laboratories Inc ., Detroit, MI) was opsonized by incubation of 10'
particles per milliliter of RPMI with 20% FCS at 37°C for 30 min under slow rotation (4
rpm) . The incubation medium was discarded after passage through a 0.22-Am Millipore
filter ; the opsonized particles were then collected from the filter with serum-free RPMI
and suspended to a concentration o£ 10' particles per milliliter .
At various time points the culture supernatant was sampled to be assayed for FIMSLUITER ET AL.
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activity. After the dishes had been cooled to 4°C, the remaining cells were recovered
from the Teflon film by careful rinsing and aspiration with pyrogen-free saline, and were
then checked for phagocytosis oflatex in cytocentrifuge preparations (14) and for viability
by trypan-blue exclusion. Afteronly 3 min, 55% ofthe cultured macrophages had ingested
latex beads. This percentage gradually increased to 90 at 6 h, and after 18 h of incubation
all of the macrophages had phagocytosed latex. During the 48-h incubation period in
serum-free medium, the viability of the cells only decreased slightly, i.e., from 95 to 80%.
In Vitro Bioassay ofFIMActivity.
￿
The FIM activity of cell lysates and culture superna-
tants was assessed by determining the stimulatory effect of the factor on the proliferation
rate of the macrophage cell line PU5-1.8 (4). For this purpose, PU5 cells obtained from
end-log-phase cultures were suspended at a concentration of 2 X 105 cells/ml in RPMI
together with 2% (vol/vol) of the cell lysate or supernatant under study and 10% FCS,
unless otherwise stated. The suspended cells were cultured for 24 h in Teflon culture
bags, after which the bags were cooled to 4°C and the cells were recovered by rinsing
and aspiration of the suspension, stained with 0.2% trypan blue in PBS, and living and
dead cells were then counted in triplicate with a Bilrker hemocytometer. As reference for
the proliferation of the macrophage cell line, PU5 cells were cultured in RPMI with 10%
FCS. Evaluation of the statistical significance of the stimulatory effect of the sample under
study was performed on the raw data. To facilitate comparison, the effect on the
proliferation of the cell line was expressed as the index of FIM activity (1), which was
calculated as the percentage increase of the number of viable cells in cultures containing
the sample under study (N,) in relation to the increase in the number of viable cells in the
reference culture (Nc), according to the formula: I = 100 X (NslNc - 1).
The effect of FIM on the proliferation rate of PU5 cells was also studied by determining
the change in the cell-cycle time of PU5 cells on the basis of the course of the stathmoki-
netic (blocked divisions) index (15). In short, 2 X 105 cells/ml were incubated in medium
containing 2% supernatant with or without FIM activity in the presence of 0.25 rig/ml
vincristine sulphate (Eli Lilly France, St. Cloud, France) in Teflon culture bags. Cells were
harvested at 2-h intervals during a 6-h incubation period, living and dead cells were
counted, cytocentrifuge preparations were made and stained with Giemsa stain, and the
percentage of cells in metaphase was determined. The cell-cycle time was assessed from
the regression line calculated by the least-squares method.
In Vivo Bioassay ofFIM Activity.
￿
FIM activity of samples was assessed in normal Swiss
mice by determination of the number of monocytes (X 10-'/ml) in blood collected from
the tail vein (6) 24 h after intravenous injection of 0.2 ml of a serial twofold dilution of
the sample under investigation, and was expressed as the difference (A) between that
value and the number of monocytes of the untreated control. The total numbers of blood
monocytes, granulocytes, and lymphocytes were calculated from the total numbers of
leukocytes counted in triplicate with a Coulter Counter (Hoek-Loos), and the differential
counts of at least 400 leukocytes in four Giemsa-stained blood smears, and they were
expressed as number per milliliter blood.
In Vivo j3HJThymidine Labeling ofMonocytes.
￿
To find out whether FIM stimulates the
production of monocytes, we followed the course of [3H]thymidine-labeled blood mono-
cytes after intravenous injection of 1 uCi [sH]thymidine (sp act, 6.7 Ci/mmol; New
England Nuclear, Boston, MA) per gram body weight together with supernatant-contain-
ing FIM. The labeling index of blood monocytes was determined in blood smears,
prepared for autoradiography as described (1), by counting 100 monocytes per mouse at
given time points; cells with three or more grains over the nucleus were considered
positive. The number of circulating labeled blood monocytes per milliliter at each time
point was calculated with the labeling-index values and the number of monocytes per
milliliter.
Ultrafiltration.
￿
Fractionation of supernatants was performed at 4 °C by centrifugation
for 5-10 min at 300 X g in Centriflo ultrafiltration cones (Amicon Corp., Lexington,
MA) with molecular weight exclusion limits of 25 X 103 (CF25) and 50 X 103 (CF50A).
For ultrafiltration through a Diaflo membrane UM10 (exclusion limit 104 mol wt) we
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4°C under an air pressure of 1 .5-2 .5 atm until the volume of the filtrate reached 60-
75% of the original sample volume.
CSF-1.
￿
The concentration of CSF-1 in culture supernatants of peritoneal cells was
determined with an RIA (16) and expressed in units per milliliter (17), mouse L cell CSF
being used as the standard (determinations kindly performed by Dr. E. R. Stanley, Albert
Einstein College of Medicine, Bronx, NY).
IL-1.
￿
The cloned murine helper T cell line D.10.G41 was used to monitor the presence
of IL-1 in culture supernatants (18). In short, T cells from a 10-14-d culture were
suspended at a concentration of 105 cells/ml in RPMI containing 5% heat-inactivated
FCS, 1 jug PHA/ml, and dilutions of the supernatant under study, and were added to flat-
bottomed microtiter wells in triplicate. The proliferative response of these cells was
measured after 72 h as the uptake of ['H]thymidine present during the last 16 h of
culture, which was determined with a Rackbeta liquid scintillation counter (LKB Produk-
ter, Bromma, Sweden).
Lysozyme and 0glucuronidase.
￿
The synthesis and secretion of lysozyme and 0-glucu-
ronidase by resident peritoneal macrophages in the presence of preopsonized latex were
assessed on the basis of the levels in the supernatant. The amount of lysozyme was
determined with the lysoplate method (19), and fl-glucuronidase was determined with
methylumbelliferyl glucuronide as substrate (20) (both assays were kindly performed by
Dr. J. Schnyder, Wander Research Institute, Berne, Switzerland).
Chemotactic Activity.
￿
The chemotactic activity towards resident peritoneal macrophages
of the culture supernatants in 5 and 10% dilutions in Gey's solution was determined with
the leading-front method (21). The assay was performed in a Millipore chamber with
nitrocellulose nitrate filters (pore size, 12,um) (Sartorius, Gottingen, Federal Republic of
Germany), as described elsewhere (11).
Endotoxin Determination.
￿
Supernatants, reagents, and glassware were checked with the
Limulus amebocyte lysate gelation test (22) (kindly performed by Dr. M. van der Veer,
National Institute for Public Health and Environmental Hygiene, Bilthoven, The Neth-
erlands), and they all were shown to contain :0.03 ng/ml endotoxin. Furthermore, in
rabbits no significant rise in rectal temperature (:50.33°C) was found over a 3-h observa-
tion period after intravenous injection of culture supernatant of up to 3 x 10' normal
peritoneal macrophages that were incubated for 18 h in the presence of latex beads.
Analysis ofData.
￿
The data given here represent the mean and one standard error. A
significant increase occurring in the in vivo or in vitro bioassay was taken as indicating
the presence of FIM in a supernatant or cell lysate under study (4, 6). In all in vivo
experiments, at least 4 but usually 8-12 mice were used per time point. The in vitro
experiments were performed in triplicate. Differences between groups were evaluated on
raw data only for significance at the 5% significance level on the basis of Student's two-
tailed test or, where appropriate, by analysis of variance according to Bonferroni (23, 24).
The strength of the linear association between the numbers of macrophages, granulo-
cytes, and lymphocytes in suspensions and FIM activity in supernatants was evaluated by
analysis ofcorrelation performed with the Pearson correlation formula (23). Unless stated
otherwise, all reported p values refer to differences relative to the untreated controls.
Results
Presence ofFIM in Lysates ofVarious Types of Cells
For identification of the types of cells containing FIM, various cell lysates were
assayed for FIM activity. The results showed that intravenous injection of lysed
resident peritoneal cells (76.9% macrophages) evoked early monocytosis in mice
and stimulated proliferation of the continuous macrophage cell-line PU5-1 .8
(Table I). Lysates of normal alveolar cells (99.2% macrophages) and PU5-1 .8
cells gave similar results. Lysates of blood granulocytes and blood lymphocytes
did not evoke a response (Table I). Lysates of a lymphoblastic cell line (L 1210)SLUITER ET AL .
￿
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TABLE I
Presence ofFIM in Lysates of Various Cells
FIMindex
* FIM activity determined in vivo andexpressed as numerical increase of blood monocytes24hafter
injection of0.2 ml ofasuspension of 107 lysed cells/ml, relative to the number of blood monocytes
of untreated mice ; meant SE .
$ Significance level of the difference relative to untreated controls; NS,P> 0.05 .
§ FIM activity determined by in vitro bioassay and expressed as percent increase of the number of
PU5 macrophages in cultures containing 2% (vol/vol) of a suspension of 10'/ml lysed cells under
investigation in relation to the value of the reference culture;mean t SE .
Negative values in vivo indicate adecrease in thenumber ofbloodmonocytes relative to untreated
mice, and in vitro, a decrease in cell proliferation relative to control .
FIGURE 1 .
￿
Course of FIM activity in the su-
pernatant ofresident peritoneal cells incubated
at a concentration of 10'/ml in theabsence (a)
and presence (b) ofpreopsonized latex particles
(latex-to-cell ratio, ^-100:1) from between 0.05
and48 h . The FIM activity was assayed in vivo
and expressed as the difference in number of
blood monocytes 24 h after injection of 0.2 ml
culture supernatant relative to the control .
Data are means plus one standard error for
triplicate experiments . 8-12 mice were used
per time point . Negative values, which were
obtained at 2 h (a)and 12 h (b), are put at zero
here, because analysis ofvariances did notshow
any significant difference relative to the con-
trol .
did not induce monocytosis in vivo either, and in vitro even retarded the
proliferation of the macrophage cell line slightly (Table I) .
In Vitro Release ofFIM
In a preliminary study (8) we found that peritoneal cells release FIM in vitro.
To study this in more detail, these cells were incubated in Teflon film dishes in
the absence and presence of a phagocytosable material . After various intervals
up to 48 h the culture supernatants were sampled for determination of FIM
activity by the in vivo assay. During incubation in the absence of latex, none of
the supernatant samples injected intravenously into recipient mice induced a
statistically significant monocytosis (p = 0.33) (Fig . 1 a) . The supernatant of
Cell type
In vivo* Ps In vitro§ Ps
X 10 3/ml %
Resident peritoneal cells 346 t 60 <0.001 25.2 t 3.2 <0.001
Resident alveolar cells ND 28.2 t 4.3 <0.001
PU5 cells 319 t 56 <0.001 ND
Blood granulocytes -651 f 26 NS 1 .8 t 1 .9 NS
Blood lymphocytes 3 t 8 NS 5.6 t 3.7 NS
L1210 53 t 36 NS -7.2 1 t 1 .9 <0.02914 MACROPHAGE ORIGIN OF FACTOR INCREASING MONOCYTOPOIESIS
FIGURE 2.
￿
Course of FIM activity in the supernatant of resident peritoneal cells of Swiss (a),
CBA (b), and C57BL (c) mice incubated in the presence ofpreopsonized latex particles (latex-
to-cell ratio, ^-100:1) from between 0.05 and 48 h . The FIM activity was assayed by the in
vitro method and expressed as percent increase of the number of PU5-1 .8 macrophages in
cultures containing 2% (vol/vol) of the supernatant under investigation in relation to the
reference culture . Data are means plus one standard error for triplicate cultures . Negative
values, which were obtained at 12 h (a), 0.5 h (b) and at 1 and 24 h (c), are put at zero here,
because analysis ofvariances did not show any significant difference relative to the control .
peritoneal cells incubated with preopsonized latex was, however, able to induce
monocytosis ; supernatant collected after 3 min of incubation caused the number
of blood monocytes in the recipients to increase by 329 X 103/ml at 24 h after
intravenous injection (p < 0.0001 for the difference relative to the control) (Fig .
I b) . The FIM activity in supernatants collected after that time point was much
lower, and became minimal at 30 min (0, 24 X 103 monocytes/ml ; p = 0.72)
before rising to a maximum (A, 235 X 103 monocytes/ml ; p < 0.009) after 2-6
h of incubation . The supernatant collected after 18 h of incubation showed
another peak of activity (p < 0.0001) that subsided slowly (Fig . 1 b) . This course
ofFIM activity in the supernatant of peritoneal cells among which macrophages
predominate (76.9%) is statistically significant (p < 0.0001 for time-dependent
effect) .
To find out whether this response is specific for Swiss mice and whether FIM
in supernatant can be detected with the in vitro assay as well, we incubated
resident peritoneal cellsof Swiss mice and twoother mouse strains in thepresence
of latex . In this experiment the course of FIM activity released by peritoneal
cells of Swiss mice, as determined on the basis of its stimulatory effect on the
proliferation rate of the macrophage cell line PU5, was almost the same as had
been found with the in-vivo assay (Fig . 2a) . Peritoneal cells from CBA and
C57BL mice released FIM into the supernatant almost instantaneously upon
exposure to latex and again in a later phase (p < 0.001 for time-dependent
effect), but the courses were not exactly the same as that found for peritoneal
cells from Swiss mice (Fig. 2, b and c) .
Effect of Inhibition ofProtein Synthesis on FIM Release in Vitro
To find out whether FIM released into the supernatant of a macrophage
suspension was newly synthesized or already present in the cells, as found in cellAddition to cultures*
SLUITER ET AL.
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TABLE II
Effect ofCycloheximide on FIM Release by
Resident Peritoneal Macrophages
FIM activity in supernatant after:
3 min
￿
6h
￿
18h
X 103/ml
￿
X 103/ml
￿
X 103/ml
None
￿
369 ± 64
￿
282 ± 74
￿
335 t 32
Cycloheximide
￿
273 ± 10
￿
188 t 49
￿
5 f 45
FIM activity expressedas theincrease in thenumber ofblood monocytes
24 h after injection of 0.2 ml culture supernatant into mice relative to
the number ofblood monocytes in untreated mice; mean ± SE.
* Preopsonized latex particles were added to 107 resident peritoneal cells
per ml (latex-to-cell ratio about 100:1) in the presence or absence of
cycloheximide in a final concentration of 0.5 ug/ml.
lysates (see above), the effect of an inhibitor of protein synthesis was studied.
The culture supernatant of resident peritoneal cells incubated for 3 min or 6 h
in the presence of preopsonized latex and 0.5 ug/ml cycloheximide contained a
significant amount ofFIM activity (p < 0.01 and p < 0.02, respectively, relative
to the controls) (Table II). After 18 h of incubation no FIM activity was shown
by the in vivo bioassay (p > 0.9). At that time point, the number ofmacrophages
containing latex and their viability did not differ from the control cultures.
Association between the Number ofPhagocytes in Various Cell Suspensions
and FIMActivity in the Supernatant
Because we wanted to know which cell type synthesizes and secretes FIM, we
incubated cell suspensions differing in composition in the presence of latex for
18 h and then determined in vivo the FIM activity in the supernatant. FIM
activity was found in the supernatant of resident peritoneal cells (Table III).
Serial twofold dilutions of the resident peritoneal cell suspension incubated for
18 h in the presence of latex showed a dose relationship between the number of
cells and FIM activity in the supernatant (Table III). This relationship can be
described by the equation n = 341-173 X 'log (dose) (r' = 0.803; p < 0.001),
where n is the increase (A) in the number of blood monocytes (X 10-'/ml) at 24
h after injection and dose is the dilution factor.
When adjusted to the same number (about 2 X 106) of macrophages, super-
natants of resident peritoneal and alveolar cells, J774.1 macrophages, and exu-
date peritoneal cells harvested 6 h after an intraperitoneal injection of latex
showed about the same FIM activity (Table III). Since the numbers ofgranulo-
cytes and lymphocytes in these cell suspensions varied, it is improbable that the
release of FIM is attributable to these two types of cell. This point was studied
in more detail by diluting a suspension of peritoneal exudate cells 100-fold to
adjust the number of granulocytes to 4 X 10', i.e., the same number as in the
resident peritoneal cell suspension. After incubation with preopsonized latex for
188, the supernatant showed no FIM activity (p > 0.05).
Ananalysis ofcorrelation performed with the presentdata showedasignificant
linear association between the number of macrophages in the cell suspension and
the FIM activity in the supernatant (r2 = 0.95; p < 0.001); a relationship between91 6 MACROPHAGE ORIGIN OF FACTOR INCREASING MONOCYTOPOIESIS
TABLE III
Correlation Between theNumber ofPhagocytes in VariousCell Suspensions and FIMActivity
in the Supernatant
* Cells of various origin were suspended in RPMI 1640 and incubated for 18 h in the presence of
preopsonized latex particles. Next, 0.2 ml ofsupernatant conditioned by the indicated number of
cells, was assayed in vivo for FIM activity. The numbers of macrophages, granulocytes, and
lymphocytes in each suspension are given, as well as the cellular composition, expressed as
percentage of total.
FIMactivity assayed in vivo and expressed as the increase in the number of blood monocytes 24 h
after injection of 0.2 ml culture supernatant, relative to the number of blood monocytes in
untreated mice; mean ± SE.
4 Exudate peritoneal cells were harvested 6 h after intraperitoneal injection of -5 X 108 latex
particlesandadjusted to obtain the same numbersofmacrophages or granulocytes as in theresident
peritoneal-cell suspension, the objective being to establish the relationship betweencell type and
theamount of FIM activity.
n Negative values indicate a decrease in the number of monocytes relative to the control mice.
FIM activity and the number ofgranulocytes (r2 =0.05;p = 0.62)or lymphocytes
(r2 = 0.14;p = 0.40) was not observed. Together, these results indicate that FIM
is secreted by macrophages and not by granulocytes or lymphocytes.
Characteristics ofFIM Derivedfrom Peritoneal Macrophages
Molecular Weight.
￿
The molecular weight of FIM present in supernatant of
peritoneal macrophages was determined by filtration of the supernatant on a
series of ultrafiltration membranes with different exclusion limits, after which
the FIM activity of the various fractions was assessed in the in vivo assay. The
results showed that macrophage-derived FIM passes through membranes that
retain molecules of >50 X 103 mol wt and must be much smaller, since mem-
branes with an exclusion limit of 25 X 103 mol wt did not retain FIM either
(Table IV). Ultrafiltration of FIM-containing macrophage supernatant through
a membrane with an exclusion limit of 10 X 103 yielded a residue that showed
significantly more FIM activity than the filtrate (p < 0.0001) and the original
supernatant did (p = 0.008) (Table IV). From these experiments it may be
concluded that the molecular weight of FIM in macrophage supernatant lies
between 10 and 25 X 103.
Half-life in Cellfree Supernatant.
￿
To establish the half-life of FIM activity at
37°C, we used the filtrate obtained from a CF25 filter (exclusion limit, 25 X
103), which will be referred to here as partiallypurified FIM (ppFIM). Incubation
Cell type
Cellular composition*
Macrophages Granulocytes Lymphocytes
FIM activity in
supernatant*
X 104 % x 104 % x 104 % x 103/ml
Resident peritoneal cells 180 90.0 4 2.0 16 8.0 331 t 64
Resident peritoneal cells 90 90.0 2 2.0 8 8.0 199 t 44
(diluted 1:2)
Resident peritoneal cells 45 90.0 1 2.0 4 8.0 36 ± 39
(diluted 1:4)
Resident alveolar cells 198 99.2 0.4 0.2 1.2 0.6 335 ± 156
J774.1 macrophages 200 100 458 f 82
Exudateperitoneal cells¢ 172 22.4 590 76.7 7.2 0.9 285 t 67
Exudateperitoneal cellsl 1.3 24.3 4 74.6 0.06 1.1 -251 ±34
(diluted 1:100)F
c`4
￿
2
to
0
0
Exclusion limit of mem-
brane
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TABLE IV
Estimation oftheMolecular Weight of FIMin Peritoneal Macrophage
Supernatant by Ultrafiltration
Unfraction
Residue
￿
Filtrate
￿
ated super-
natant
M
￿
x 105/ml
￿
x 103/ml
￿
x 103/ml
50 x 103 (CF50)
￿
119± 55
￿
234 t 61
￿
218 t 51
25 x 103(CF25)
￿
26 t 38
￿
527 ± 74
￿
240 t 88
lox 105 (UM10)
￿
510 ± 82
￿
-20* ± 48
￿
198 ± 86
FIM activity ofeach fraction assayed in vivoandexpressedas theincrease
in thenumber of bloodmonocytes 24 hafterinjection of0.2 ml, relative
to the number of blood monocytesin untreated mice, mean t SE.
* Negative values indicate a decrease in thenumber of monocytesrelative
to the control mice.
Iz zc
￿
48 n
Hours after i.v. injection
FIGURE 3.
￿
Course of the number of blood mon-
ocytes (O), lymphocytes (p), and granulocytes (A)
per milliliter after intravenous infection of 0.2 ml
ofppFIM. Dataaremeansplus onestandard error.
8-12 mice were used per time point.
of ppFIM for various intervals at 37 °C before in vivo assay of residual FIM
activity showed rapid inactivation with a half-time of about 2.5 min. During
incubation of ppFIM at 37°C, addition of 0.5 mg/ml soybean trypsin inhibitor,
which did not itself induce monocytosis (p > 0.5), inhibited the degradation of
the activity of FIM for at least 45 min.
Cell-lineage Specificity.
￿
The cell-lineage specificity of ppFIM was studied by
intravenous injection of 0.2 ml into mice. The number of blood monocytes
increased from 338 (± 32 SE) X 103 monocytes/ml to a maximum of 775 (± 70
SE) X 10' monocytes/ml 24 h afterthe injection (p < 0.0001), and then gradually
decreased, returning to control values at 72 h (p < 0.0001 for time-dependent
effect) (Fig. 3). The number of blood granulocytes showed only a small and
insignificant (p = 0.28) increase from 835 (± 117 SE) X 10' cells/ml to 1225 (±
237 SE) X 103 cells/ml at 12 h and then remained at that level for the rest of
the observation period (p = 0.48 for time-dependent effect) (Fig. 3). The number
of blood lymphocytes decreased slightly from 11 .0 (± 1.2 SE) X 106/ml to 8.3
(± 1 .2 SE) X 106/ml at 12 h (p = 0.16), but returned to the control level at 24
h (p = 0.15 for time-dependent effect).
Stimulation of the Production of Monocytes in the Bone Marrow.
￿
The course of
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FIGURE 4.
￿
Course of the number of labeled cir-
culating blood monocltespermilliliter afterintra-
venous injection of [ Mthymidine together with
0.2 ml ppFIM (O), and the course of the number
of labeled blood monocytes per milliliter during
the normal steady state (p) as derived from refer-
ence 1. Data are means plus one standard error.
8-12 mice were used pertime point.
0 11 24 48 71 96
Hours after iv injection
the effects of stimulation of monocyte production in the bone marrow. After
intravenous injection ofppFIM together with [3H]thymidine into Swiss mice, the
number of labeled monocytes in the blood increased rapidly to a maximum of
2.78 (± 0.41 SE) x 105 cells/ml at 24 h, which is twice the increase in the number
of labeled monocytes in normal mice given only an injection of [sH]thymidine
(p = 0.0002) (Fig. 4). During the next 24 h the number oflabeled monocytes in
mice given ppFIM gradually decreased. At 48 h the difference with respect to
normal mice amounted to only 25%, and after that time point the numerical
course of the labeled monocytes was similar under both conditions (Fig. 4).
Effect on the Cell-cycle Time ofthe Macrophage Cell Line PU5.
￿
During incubation
of PU5 cells in the presence ofppFIM with an in vitro FIM index of 18.3% and
vincristine, the percentage of cells arrested in metaphase increased from 4.1
(± 0.5 SE) at 0 h to 41.1% (± 1.2 SE) at 6 h. Calculated with these values, the
cell-cycle time of PU5 cells amounted to 16.3 h, that of the controls to 23.8 h.
Thus, ppFIM decreased the cell-cycle time by 31.3%, which is greater than the
effect on the population doubling time, i.e., a decrease of 18.3% relative to the
control. This indicates that the FIM index underestimates the effect of FIM on
the rate of proliferation of PU5 cells, in all probability because a proportion of
the PU5 cells die during incubation and therefore the increase in the number of
the cells is smaller than would be expected from the cell-cycle time.
Presence ofOther Biologically Active Factors in Peritoneal Cell Supernatant
The presence of other factors relevant for the regulation of proliferation of
monocyte precursors was studied in peritoneal macrophage supernatants with an
FIM index of22.7%. The supernatant contained only 10 U CSF-1 per milliliter,
had no IL-1 activity, and showed no chemotactic activity. This supernatant
contained 0.217 Ag lysozyme and 2.5 mU ,#-glucuronidase per milliliter, which
indicates that other biologically active substances were secreted normally under
the culture conditions applied.
Discussion
The main conclusion to be drawn from the present study is that macrophages
contain and are able to synthesize and secrete FIM. Granulocytes and lympho-
cytes neither contain nor secrete FIM.SLUITER ET AL.
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FIM was found in lysates and supernatants of cultures of resident and exudate
peritoneal and alveolar macrophages and a macrophage cell line. After exposure
of phagocytosable particles, the macrophages released FIM into the culture
supernatant, the course of the release showing a biphasic pattern, which is in
agreement with preliminary findings (8). This pattern of FIM release is signifi-
cant, because the standard deviation is much smaller at each time point than the
fluctuation of the level of FIM activity in time, and is in all likelihooddetermined
by the rates of synthesis, secretion, and in vitro inactivation, since FIM is readily
inactivated by proteolytic enzymes in the culture supernatant. Thus, after the
secretion of preformed FIM upon phagocytosis of particles, FIM synthesis
recommences and this newly synthesized FIM is secreted too.
The characteristics of macrophage-derived FIM are in many respects similar
to those of FIM in serum. The estimated molecular weight of macrophage-
derived FIM lies between 10 and 25 X 103 and that of FIM in serum between
18 and 25 X 10' . In all likelihood, macrophage-derived FIM, like FIM in serum,
is a protein, its synthesis being inhibited by cycloheximide. Both FIMs stimulate
the production of monocytes in the bone marrow. The courses of the labeled
blood monocytes are not entirely identical; in the present study an injection of
macrophage-derived FIM led to a maximum of 2.8 X 105 labeled monocytes per
milliliter at 24 h followed by a gradual decrease to 0.8 X 105 per milliliter at 96
h, whereas an injection of serum containing FIM led to a further increase to a
maximum of 5.1 X 105 cells per milliliter at 48 h (3). This difference could be
due to either a smaller amount of FIM in FIM-containing macrophage superna-
tant (protein concentration, 0.82 mg/ml) than that in serum or to the difference
in the half-life of FIM at 37 ° C, which was 2.5 min in macrophage supernatant
and about 25 min in serum (7). In addition, the kinetic studies showed that
macrophage-derived FIM is cell-lineage specific since it does not have any effect
on the production of granulocytes or lymphocytes.
During inflammation induced by an intraperitoneal injection of latex, FIM
activity in the serum, unlike that in supernatants of resident peritoneal macro-
phages incubated with preopsonized latex in vitro, increased steadily to a maxi-
mum at 18 h and then decreased gradually (3). No explanation can be offered
for the more gradual increase of FIM activity in the circulation, but it seems
possible that a loss of synchronization of FIM secretion after the injection of
latex might be responsible, since, in contrast to the in vitro situation where the
number of macrophages is constant, the number of FIM-secreting macrophages
in the inflammatory exudate gradually increases.
For the present study, we used an in vivo and an in vitro bioassay with equal
sensitivity for the detection of FIM activity in culture supernatants. The in vivo
assay is based on the ability of monocyte precursors in the bone marrow to
respond to FIM by increased monocyte production, which is measured as the
increase in the number of monocytes in the circulation . The reliability of this
assay for assessment of the stimulation of monocyte production is evident from
the finding that the increase in the number of [sH]thymidine-labeled monocytes
was greater after injection of supernatant with FIM activity than for the controls.
The validity of the in vitro assay, which is based on the ability of the continuous
macrophage cell line PU5 to respond with an increased rate of proliferation, is920 MACROPHAGE ORIGIN OF FACTOR INCREASING MONOCYTOPOIESIS
shown by the decrease of the cell-cycle time ofPU5 cells cultured in the presence
of FIM. Assay of FIM in vitro based on its effect on the cell-cycle time instead
of on the population-doubling time is more sensitive but more laborious and
therefore is not suitable for routine use.
What is the relevance of the present findings? Tissue macrophages are among
the first cells to come into contact with deleterious material that must be
eliminated. This requires a rather large number ofphagocytes at the site where
such material has become localized. The necessary increase in macrophages is
effectuated by an influx of monocytes. The present results show that the
macrophages themselves regulate the supply ofcirculating monocytes by stimu-
lating the increase in the production of monocytes in the bone marrow via the
secretion ofFIM during phagocytosis.
Summary
Earlier investigations (3, 5, 8) had indicated that the factor increasing mono-
cytopoiesis (FIM), present in the serum of mice and rabbits during the onset of
an inflammatory response, is released by cells ofthe inflammatory exudate. The
present study was performed to determine which cells produce and secrete this
factor and to establish the kinetics of its production and secretion. FIM was
assayed in vivo by intravenous injection of samples into untreated mice and
monitoring the course ofthe number ofblood monocytes in the recipients. FIM
was assayed in vitro by adding samples to cultures of the macrophage cell line
PU5 and determining the rate ofproliferation ofthe cells.
The results show that only macrophages contain and synthesize FIM. This
factor is secreted upon exposure to a phagocytic stimulus, and after the release
of preformed FIM, macrophages secrete newly synthesized FIM. Granulocytes
and lymphocytes neither contain nor secrete FIM.
The characteristics ofFIM derived from macrophages are in all aspects similar
to those ofFIM in serum. Macrophage-derived FIM isa protein with a molecular
weight between 10 and 25 X 1Os, its activity is cell-lineage specific and dose
dependent, and it stimulates monocyte production in the bone marrow. Macro-
phage-derived FIM is not identical to either CSF-I or IL-1, and has no chemo-
tactic activity.
Taken together, the present results show that FIM occurring in serum during
an inflammatory response originates from macrophages at the site ofthe inflam-
mation. In this waythe macrophages themselves regulate the supply ofcirculating
blood monocytes that can migrate to the site of injury when needed.
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